Major navigation

Corporate R&D/Health

Jisc Collections provides negotiation, licensing and related services and assistance for organisations in the pharmaceutical/biotechnology and health sectors:

  • Global pharmaceutical and biotech companies
  • NHS and NHS regional consortia
  • Health related groups and institutions

Our core focus is negotiating preferential access rights, and establishing favourable terms and conditions for the users of digital information in line with your strategic objectives. This includes:

  • gaining trial terms with publishers as a basis for decision-making
  • obtaining the best possible prices for content
  • ensuring the widest possible access
  • delivering the most favourable licence terms and conditions

In representing your organisation or consortium in direct negotiations with publishers, we attempt to achieve all of the above, in addition to providing regular feedback and reporting on the status of discussions, and delivering an agreement that meets your financial, technical, and legal requirements.

We have provided services for:

  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi-Aventis
  • Novartis
  • Biotech micro SMEs in Daresbury and Edinburgh. Following the Finch Report, Jisc Collections managed a usage analysis pilot during 2014/15 supporting the Corporate SME sectors.  Details of the pilot and the public report are available here:  SME


Please contact Carolyn Alderson, Deputy Director, if you are interested in discussing how Jisc Collections can make a difference. 

Last updated: Februrary 2017